Nous utilisons des cookies pour nous assurer que nous vous offrons la meilleure expérience possible sur notre site web.
Yverdon-les-Bains, Switzerland. – Symbios today announced the launch of the ORIGIN® CR Total Knee System, which completes the ORIGIN® product range with both monobloc and modular cruciate-retaining versions, that will allow surgeons to proceed to custom-made knee replacement preserving the posterior cruciate ligament (PCL).
As a cruciate-retaining implant type, the ORIGIN® CR Total Knee System relies on the same design fundamentals as the ORIGIN® PS Total Knee System which has been marketed since 2018 by Symbios, and intends to restore each individual’s knee alignment, shape and kinematics to improve patients’ satisfaction and clinical outcomes.
“The cruciate-retaining market segment corresponds to approximately 50-60% of the total primary knee replacement market, depending on geographies and surgical preferences” commented Florent Plé, President and CEO of Symbios. “We are very excited about this product launch as many surgeons have been looking forward to this cruciate-retaining version of our ORIGIN® custom-made knee implant, and as it will correspond better to their surgical preferences. This extension of the ORIGIN® product range opens up a wide field of market opportunities for Symbios, and will contribute to make custom-made knee replacement accessible to more and more patients around the world.”
To learn more about Symbios ORIGIN® Total Knee System, please visit www.symbios.ch.
